Clover Health Investments, Corp. announced that on January 6, 2023, the Board of Directors of the company appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective immediately. Ms. Reynoso had previously served as Chief Operating Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +3.42% |
|
+18.90% | +58.60% |
Jun. 26 | Clover Health Investments Regains Compliance With Nasdaq Listing Rule | MT |
May. 29 | Clover Health Investments to Offer AI Tool 'Clover Assistant' Outside Medicare Plan | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.60% | 750M | |
-2.85% | 471B | |
+13.57% | 124B | |
+11.80% | 95.11B | |
-16.51% | 46.06B | |
-18.81% | 17.19B | |
-22.14% | 2.76B | |
+3.02% | 1.7B |
- Stock Market
- Equities
- CLOV Stock
- News Clover Health Investments, Corp.
- Clover Health Investments, Corp. Appoints Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage